Osteopontin in relation to Prognosis following Coronary Artery Bypass Graft Surgery

Eftihia Sbarouni1, Panagiota Georgiadou1, Sofia Chatzikyriakou1

  • 12nd Division of Interventional Cardiology, Onassis Cardiac Surgery Center, 17674 Athens, Greece.

Disease Markers
|September 7, 2016
PubMed

Insights

Preoperative osteopontin (OPN) levels in patients undergoing coronary artery bypass grafting (CABG) were assessed. While OPN correlated with risk factors like prior heart attack, it did not independently predict adverse cardiovascular events post-surgery.

Area of Science:

  • Cardiology
  • Biomarkers
  • Cardiac Surgery

Background:

  • Cardiovascular events can occur post-coronary artery bypass grafting (CABG) despite complete revascularization.
  • Osteopontin (OPN) is a protein that may play a role in cardiovascular disease.
  • Preoperative risk assessment is crucial for patients undergoing CABG.

Purpose of the Study:

  • To investigate the association between preoperative osteopontin (OPN) levels and cardiovascular outcomes in patients undergoing elective Coronary Artery Bypass Grafting (CABG).
  • To determine if OPN levels can predict major adverse cardiovascular events after CABG surgery.

Main Methods:

  • Prospective study of 131 patients undergoing elective CABG with measurement of preoperative plasma osteopontin (OPN) levels.
  • Patients were followed for a median of 12 months for a composite endpoint of cardiovascular death, nonfatal myocardial infarction, repeat revascularization, or hospitalization.
  • Statistical analysis included comparisons between groups and hazard ratio calculations.

Main Results:

  • Patients with a history of acute myocardial infarction (AMI) had significantly higher preoperative OPN levels.
  • Preoperative OPN levels showed a positive correlation with the logistic EuroScore.
  • Preoperative OPN levels did not differ between patients with and without major adverse events during follow-up and did not independently predict outcomes.

Conclusions:

  • Osteopontin (OPN) is associated with preoperative risk factors in patients undergoing low-risk Coronary Artery Bypass Grafting (CABG), including prior acute myocardial infarction and EuroScore.
  • OPN did not independently predict adverse cardiovascular events in this patient cohort.
  • Further research may explore the role of OPN in cardiovascular disease pathogenesis or as a biomarker in different clinical settings.

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
510
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
414
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363